← FDA Drug Approvals (Drugs@FDA)

CYCLOPHOSPHAMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-12-18

Drug application

FDA Application #
ANDA216958
Application type
Abbreviated New Drug Application (Generic)
Brand name
CYCLOPHOSPHAMIDE
Generic name
Cyclophosphamide
Active ingredients
CYCLOPHOSPHAMIDE
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Prescription
Sponsor
HIKMA
First approval
2023-12-18

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown